Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing

por Luedemann, Max, Stadler, Daniela, Cheng, Cho-Chin, Protzer, Ulrike, Knolle, Percy A., Donakonda, Sainitin
Publicado 2022